Drug Industry Articles & Analysis
13 articles found
Compounds of phosphorus play a pivotal role in various fields, notably pharmaceuticals and industrial chemistry. Their unique chemical properties, such as reactivity and ability to form diverse structures, make them invaluable in drug synthesis and other industrial applications. ...
The scientific realm behind the development and evaluation of therapeutic drugs, pesticides, industrial and environmental chemicals profoundly relies on a field of research called Pharmacokinetic/Toxicokinetic (PK/TK) studies. ...
They are widely used in the pharmaceutical and biotechnology industries for drug delivery, controlled release systems, and other applications due to their unique properties and versatility. ...
In moments like this, I can’t help but pause and reflect on those pre-Recursion days in Dean’s lab, and the discoveries that led us to embrace a new approach to drug discovery. We’ve come a long way since then, but the fundamental principles that guided our work in CCM are still central to our work today. ...
After a few years of working as a software engineer in the aerospace and defense industry, I began to wonder what I was doing with my life developing tools for military purposes. ...
At Recursion, we are working to decode biology and industrialize drug discovery. We have successfully executed over 82 million phenomic experiments and inferred over 179 billion biological relationships in our quest to identify promising novel therapeutic approaches. ...
As a frontier in quantum chemistry, the calculation of excited states plays an important role in accelerating the discovery and research of new things, such as drugs, experimental materials and industrial catalysts, and has been widely loved and pursued by scientists and researchers in various fields. ...
As the complexity of advanced therapies continues to grow, more data is needed to establish a drug’s mode of action, efficacy, and long-term safety. It’s no wonder, then, that big data is fueling the drive for tomorrow’s therapies. ...
Emphasis is placed on relations between the genomics sector and its larger pharmaceutical and biotechnology counterparts, and to the financial markets on which drug innovation ultimately rests. The analysis combines historical and sociological approaches to the study of innovation, and situates genomics within the wider context of the commercialisation of the life sciences. In ...
MFI™ for Parenteral Drugs USP Chapter 788 (Particulate Matter in Injections) describes physical tests to be performed for the purpose of enumerating subvisible particles within specific size ranges. ...
We report the use of a modified membrane protein hyperexpression system to characterize three classes of fungal membrane proteins (ABC transporters Pdr5p, CaCdr1p, CaCdr2p, CgCdr1p, CgPdh1p, CkAbc1p, and CneMdr1p, the major facilitator superfamily transporter CaMdr1p, and the cytochrome P450 enzyme CaErg11p) that contribute to the drug resistance phenotypes of five pathogenic ...
Normal quality control procedures involve accepting a “lot” of a raw material from a supplier and then performing a series of tests to determine if the material is suitable for use in a manufacturing process. For the drug manufacturing industry, as well as many others, this is both a critical and time-consuming (and occasionally costly) step in the ...
In this paper, preliminary results of a research project on strategies of drug delivery companies (DDC) are presented to discuss the changing role of technology suppliers in the pharmaceutical industry. Changes in the pharmaceutical industry are presented briefly and related to developments in the drug delivery ...